CHARLES TOWN, W.V., Feb. 13 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA, announces 2007 sales up 89% over last year, details are available on their Annual Report on http://www.pinksheets.com/.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"The company's growth has continued upward despite the nation's concerns about economic recession and the weakening dollar. We expect to maintain that stable growth pattern in 2008 based upon several factors 1) we manufacture and sell our own products, 2) our products are medical in nature and are essential to our customers, representing a less expensive while more effective alternative to traditional therapies, 3) we have a strong overseas market for our products, where consumers are anxious to buy U.S. products with their stronger currencies" states David Phillips, Ph.D., CEO of RBRM. RBRM's annual shareholder meeting is scheduled for 3pm on February 14, 2008.
For more information visit: http://www.rebuildermedical.com/, http://www.molluscum.com/.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk,
